|
|
Volumn 12, Issue 8, 2014, Pages 443-451
|
|
Controversies in ASSAY and drug development technologies: A focus on assessing irreproducibility
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
DIMETHYL SULFOXIDE;
ARTICLE;
CANCER RESEARCH;
COST BENEFIT ANALYSIS;
DRUG DEVELOPMENT;
DRUG EFFICACY;
EC50;
HUMAN;
IC50;
IN VITRO STUDY;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
MEASUREMENT ACCURACY;
MEDICAL TECHNOLOGY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PERSONAL EXPERIENCE;
PROTEIN PROCESSING;
PROTEIN PURIFICATION;
REPRODUCIBILITY;
SURVIVAL RATE;
TIME;
ANIMAL;
HIGH THROUGHPUT SCREENING;
STANDARDS;
ANIMALS;
DRUG DISCOVERY;
HIGH-THROUGHPUT SCREENING ASSAYS;
HUMANS;
REPRODUCIBILITY OF RESULTS;
|
|
EID: 84909943961
PISSN: 1540658X
EISSN: 15578127
Source Type: Journal
DOI: 10.1089/adt.2014.1501 Document Type: Article |
|
Times cited : (1)
|
|
References (5)
|
